Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators

被引:37
作者
Huttunen, M
Hyttinen, M
Nilsson, G
Butterfield, JH
Horsmanheimo, M
Harvima, IT
机构
[1] Kuopio Univ Hosp, Dept Dermatol, Kuopio 70211, Finland
[2] Univ Kuopio, Dept Anat, FIN-70211 Kuopio, Finland
[3] Univ Uppsala, Dept Pathol, Uppsala, Sweden
[4] Mayo Clin, Dept Allerg Dis & Internal Med, Rochester, MN USA
关键词
mast cell; keratinocyte; skin culture; epithelialization; histamine; heparin;
D O I
10.1034/j.1600-0625.2001.010003184.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Mast cells are suggested to participate in regenerative processes, but their influence on epithelialization and wound healing has not been well studied. Since mast cells can be found in contact with epidermis in chronic inflammatory skin diseases and venous ulcers, the effect of mast cells on keratinocyte growth was studied. Keratinocytes were cultured in serum-free conditions with (complete medium) or without (basal medium) epidermal growth factor (BPE) and bovine pituitary extract (BPE) to reach subconfluence in a 24-well plate, and the cells were treated with different mast cell mediators histamine, heparin and tryptase, or lysate from HMC-1 cells, a human leukemic mast cell line. Whole skin cultures were used as a model for in vitro wounds to study the effect of mast cells on epithelial outgrowth from skin specimens. Histamine inhibited H-3-thymidine incorporation of keratinocytes dose-dependently by 29% at 1 mM, and 89% at 5 mM histamine. In whole skin culture, histamine inhibited epithelial outgrowth dose-dependently by 64% already at 0.1 mM histamine and maximally (91%) at 1 mM histamine. Heparin inhibited H-3-thymidine incorporation dose-dependently by up to 33% at 2 mug/ml in the absence, but not in the presence, of EGF/BPE. In contrast, in whole skin culture, heparin first inhibited the epithelial outgrowth by up to 27% at 2 mug/ml, but then reversed the inhibition to 30% stimulation at 200 mug/ml. Skin tryptase (0.0285 to 2.85 mug/ml) with or without heparin (0.5 to 20 mug/ml) did not affect thymidine incorporation in keratinocytes. Lysate from HMC-1 cells, but not that from control, neuroblastoma cells, inhibited 3H-thymidine incorporation in keratinocytes dose-dependently, and maximal (47%) inhibition was reached with 16,700 lysed HMC-1 cells/ml. In whole skin culture, HMC-1 lysate inhibited the epithelial outgrowth by up to 36% at 67,000 lysed cells/ml. The results show that mast cells and their mediators are inhibitory to keratinocyte H-3-thymidine incorporation and epithelial outgrowth in vitro, although, the inhibitory effect of histamine was seen at high concentrations suggesting a requirement for close morphologic vicinity of mast cells to keratinocytes. Thus, mast cells are assumed to control epidermal regeneration and to impair epithelialization of chronic ulcers.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 46 条
[1]   EFFECT OF HISTAMINE AND DIVALENT-CATIONS ON THE ACTIVITY AND STABILITY OF TRYPTASE FROM HUMAN MAST-CELLS [J].
ALTER, SC ;
SCHWARTZ, LB .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 991 (03) :426-430
[2]   THE EFFECT OF HISTAMINE ON EPIDERMAL OUTGROWTH - ITS POSSIBLE DUAL ROLE AS AN INHIBITOR AND STIMULATOR [J].
AOYAGI, T ;
ADACHI, K ;
HALPRIN, KM ;
LEVINE, V ;
WOODYARD, CW .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1981, 76 (01) :24-27
[3]  
BIEDLER JL, 1973, CANCER RES, V33, P2643
[4]   Human mast cells stimulate vascular tribe formation - Tryptase is a novel, potent angiogenic factor [J].
Blair, RJ ;
Meng, H ;
Marchese, MJ ;
Ren, SL ;
Schwartz, LB ;
Tonnesen, MG ;
Gruber, BL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (11) :2691-2700
[5]   MAST-CELLS IN HUMAN ULCERS [J].
BOLTON, LL ;
MONTAGNA, W .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1993, 15 (02) :133-138
[6]   THE EFFECT OF HISTAMINE AND A HISTAMINE-RELEASING AGENT (COMPOUND 48-80) ON WOUND HEALING [J].
BOYD, JF ;
SMITH, AN .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1959, 78 (02) :379-&
[7]  
BRADDING P, 1993, J IMMUNOL, V151, P3853
[8]   INTERLEUKIN-4 IS LOCALIZED TO AND RELEASED BY HUMAN MAST-CELLS [J].
BRADDING, P ;
FEATHER, IH ;
HOWARTH, PH ;
MUELLER, R ;
ROBERTS, JA ;
BRITTEN, K ;
BEWS, JPA ;
HUNT, TC ;
OKAYAMA, Y ;
HEUSSER, CH ;
BULLOCK, GR ;
CHURCH, MK ;
HOLGATE, ST .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1381-1386
[10]   ACTIVATED MAST-CELLS PRODUCE INTERLEUKIN-13 [J].
BURD, PR ;
THOMPSON, WC ;
MAX, EE ;
MILLS, FC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1373-1380